VRTX
55
2
MOS
43
-5
AAL
51
-3
FDX
44
-2
INTU
56
3
LLY
53
6
ZION
69
-2
ABBV
50
8
AMG
57
2
OI
38
-5
CVX
46
8
XOM
40
-7
ADSK
68
-2
RIG
55
-6
DLTR
40
-2
DG
6
-4
BA
56
-2
NKE
39
-3
HSIC
60
-2
AMZN
59
3
VRTX
55
2
MOS
43
-5
AAL
51
-3
FDX
44
-2
INTU
56
3
LLY
53
6
ZION
69
-2
ABBV
50
8
AMG
57
2
OI
38
-5
CVX
46
8
XOM
40
-7
ADSK
68
-2
RIG
55
-6
DLTR
40
-2
DG
6
-4
BA
56
-2
NKE
39
-3
HSIC
60
-2
AMZN
59
3
Financhill
Back

BridgeBio Pharma Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
75

BBIO
BridgeBio Pharma

Last Price:
27.77
Seasonality Move:
10.74%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
251.14
Seasonality Move:
7.55%
Buy
75
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $26.44. The Score for BBIO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $253.35. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $26.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $253.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 58.19 Buy
Chaikin Money Flow: -946431 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.3 - 25.9) Buy
Bollinger Bands (100): (24.02 - 27.44) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.33 Sell
Relative Strength Index (14 RSI): 44.29 Sell
Chaikin Money Flow: 851531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (247.71 - 283.73) Sell
Bollinger Bands (100): (248.8 - 281.72) Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.99 Buy
20-day SMA: 24.68 Buy
50-day SMA: 24.98 Buy
200-day SMA: 27.22 Sell
8-day EMA: 24.82 Buy
20-day EMA: 24.67 Buy
50-day EMA: 25.07 Buy
200-day EMA: 26.49 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 243.36 Buy
20-day SMA: 259.9 Sell
50-day SMA: 271.86 Sell
200-day SMA: 212.45 Buy
8-day EMA: 249.92 Buy
20-day EMA: 258.06 Sell
50-day EMA: 264.29 Sell
200-day EMA: 231.45 Buy

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $1.07 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):